2010 Speakers
| A | |||
| Margaret Anderson Executive Director FasterCures |
|||
| Christopher P. Austin Director National Institutes of Health, Chemical Genomics Center |
|||
| Susan Axelrod Chair and Founding Member Citizens United for Research in Epilepsy |
|||
| B | |||
| Dana A. Ball Program Director The Leona M. and Harry B. Helmsley Charitable Trust |
|||
| Alex Barkas Managing Director Prospect Venture Partners |
|||
| Anna Barker Consultant (Former Deputy Director, and Deputy Director for Strategic Scientific Initiatives) National Cancer Institute |
|||
| Ernest A. Bates Founder, Chairman of the Board and Chief Executive Officer American Shared Hospital Services |
|||
| Robert J. Beall, Ph.D. President and CEO Cystic Fibrosis Foundation |
|||
| Alpheus Bingham Co-Founder and Member, Board of Directors Innocentive |
|||
| Robi Blumenstein President CHDI Management |
|||
| Luciana Borio Senior Advisor for Medicine and Public Health Office of the Chief Scientist, Office of the Commissioner U.S. Food and Drug Administration |
|||
| David Bowen Deputy Director Government Relations and Global Health Policy and Advocacy The Bill and Melinda Gates Foundation |
|||
| Barry Bunin Chief Executive Officer and Board Director Collaborative Drug Discovery |
|||
| C | |||
| Robert M. Califf Vice Chancellor for Clinical Research, Director of the Duke Translational Medicine Institute, and Professor of Medicine in the Division of Cardiology Duke University Medical Center |
|||
| Walter Capone Chief Operating Officer Multiple Myeloma Research Foundation |
|||
| Randall L. Carpenter Co-Founder, President and CEO Seaside Therapeutics |
|||
| John Castellani President & Chief Executive Officer Pharmaceutical Research and Manufacturers of America |
|||
| Paul Chew Senior Vice President, U.S. Chief Science Officer/Chief Medical Officer Sanofi-Aventis |
|||
| Erez Chimovits Managing Director, Israeli Investment Team OrbiMed |
|||
| Carolyn M. Clancy Director Agency for Healthcare Research and Quality |
|||
| Adam Clark Director of Scientific and Federal Affairs FasterCures |
|||
| Delos (Toby) Cosgrove Chief Executive Officer and President Cleveland Clinic |
|||
| John Crowley President and Chief Executive Officer Amicus Therapeutics, Inc. |
|||
| D | |||
| Ross DeVol Executive Director, Economic Research Milken Institute |
|||
| Jesse Dylan Founder, Lybba.org Filmmaker, Creative Director and CEO, FreeForm |
|||
| E | |||
| Steve Engle Chairman and CEO, XOMA Ltd. |
|||
| F | |||
| Maria C. Freire President The Albert and Mary Lasker Foundation |
|||
| Stephen Friend President, Co-Founder and Director Sage Bionetworks |
|||
| G | |||
| Chris Garabedian Vice President of Corporate Strategy Celgene Corporation Gordon Gund Co-Founder and Chairman Foundation Fighting Blindness |
|||
| H | |||
| Margaret Hamburg Commissioner U.S. Food and Drug Administration |
|||
| Jeff Hammerbacher Vice President Products, Cloudera, Inc. |
|||
| Jonathan A. Handler Chief Deployment Architect Microsoft Corporation |
|||
| Katie Hood Chief Executive Officer Michael J. Fox Foundation for Parkinson's Research |
|||
| Kathy Hudson Deputy Director for Science, Outreach, and Policy National Institutes of Health |
|||
| J | |||
| Harry Johns President and CEO Alzheimer's Association |
|||
| K | |||
| Kenneth Kelley Executive Chairman and Chief Executive Officer PaxVax, Inc. |
|||
| Kavita K. Patel Former Director of Policy White House Office of Public Engagement |
|||
| L | |||
| Debra Lappin President, Council for American Medical Innovation |
|||
| Freda C. Lewis-Hall Senior Vice President & Chief Medical Officer Pfizer, Inc. |
|||
| Jonathan Leff Managing Director Warburg Pincus |
|||
| Christian Loucq Director PATH Malaria Vaccine Initiative |
|||
| Susan Love President & Medical Director Dr. Susan Love Research Foundation |
|||
| M | |||
| Usama Malik Vice President Worldwide Innovation & Diversified Business Strategy Worldwide Business Development, Strategy & Innovation, Pfizer, Inc. |
|||
| Kenneth D. Mandl Director of the Intelligent Health Laboratory Children's Hospital Informatics Program |
|||
| Alfred E. Mann Chairman and Chief Executive Officer MannKind Corporation |
|||
| Kate Marusina Manager, Research Facilitation and Industry Alliance Clinical and Translational Science Center, UC Davis School of Medicine |
|||
| James McCullough CEO, Exosome Diagnostics, Inc. |
|||
| Richard Merkin Founder, CEO, and President Heritage Provider Network |
|||
| Michael Milken Chairman, FasterCures Chairman, The Milken Institute |
|||
| Lesa Mitchell Vice President Ewing Marion Kauffman Foundation |
|||
| Melinda Moree CEO BIO Ventures for Global Health |
|||
| Sridhar Mosur President and CEO of Global Drug Discovery and Development Jubilant Life Sciences Ltd. |
|||
| Bernard Munos Advisor, Corporate Strategy Eli Lilly and Co. |
|||
| N | |||
| Garry Neil Corporate Vice President, Office of Science and Technology Johnson & Johnson |
|||
| David Nicholson Senior Vice President and Head Worldwide Licensing and Knowledge Management Merck & Co., Inc. |
|||
| Solomon Nwaka Head of Discovery and Innovation Research Unit WHO/TDR |
|||
| P | |||
| Gregory Petsko Professor of Biochemistry and Chemistry Brandeis University |
|||
| Heather Preston Managing Director TPG Biotech |
|||
| Dennis Purcell Senior Managing Partner Aisling Capital |
|||
| R | |||
| Arti K. Rai Elvin R. Latty Professor of Law Duke Law School |
|||
| Cynthia Rice Vice President of Government Relations Juvenile Diabetes Research Foundation |
|||
| S | |||
| Robert Sebbag Vice President Access to Medicines Sanofi- Aventis |
|||
| Wendy Selig President and CEO Melanoma Research Alliance |
|||
| Vicki L. Seyfert-Margolis Senior Advisor, Science Innovation and Policy U.S. Food and Drug Administration |
|||
| Bennett Shapiro Senior Partner, Puretech Ventures Director, DNDi Chairman, DNDi-North America |
|||
| Samuel C. Silverstein John C. Dalton Professor Department of Physiology and Cellular Biophysics, Columbia University |
|||
| Greg Simon Senior Vice President, Worldwide Policy Pfizer, Inc. |
|||
| Mark Simon President, Williver Group LLC Advisor, Torreya Partners |
|||
| Jonathan Simons President and CEO Prostate Cancer Foundation |
|||
| Josh Sommer Executive Director Chordoma Foundation |
|||
| Howard Soule Executive Vice President: and Chief Science Officer Prostate Cancer Foundation |
|||
| Brian Sullivan News Anchor Fox Business Network |
|||
| T | |||
| Paul Tang Internist and Vice President, Chief Medical Information Officer Palo Alto Medical Foundation |
|||
| Wendy Taylor Senior Advisor, Innovative Finance and Public Private Partnerships United States Agency for International Development |
|||
| Elizabeth Thompson President Susan G. Komen for the Cure |
|||
| U | |||
| Steve Usdin Senior Editor (Washington) BioCentury |
|||
| V | |||
| Chris Varma Entrepreneur-in-Residence Third Rock Ventures |
|||
W |
|||
| Christopher Wasden Managing Director US PricewaterhouseCoopers Healthcare Strategy and Innovation Practice |
|||
| John Wilbanks Vice President for Science Creative Commons |
|||
| Janet Woodcock Director of the Center for Drug Evaluation and Research U.S. Food and Drug Administration |
|||
|
Y |
|||
| Keith Yamamoto Professor of Cellular and Molecular Pharmcology Executive Dean of the School of Medicine, University of California San Francisco |
|||